ClinicalTrials.gov record
Terminated Phase 4 Interventional Accepts healthy volunteers

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

ClinicalTrials.gov ID: NCT03537768

Public ClinicalTrials.gov record NCT03537768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 2:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized Study of the Efficacy of Ulipristal Acetate (UPA) 30 mg, Levonorgestrel (LNG) 1.5 mg, and LNG 3.0 mg for Emergency Contraception (EC) in Women With Weight ≥ 80 kg

Study identification

NCT ID
NCT03537768
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Kimberly Myer
Other
Enrollment
532 participants

Conditions and interventions

Conditions

Interventions

  • Levonorgestrel Drug
  • Ulipristal Acetate Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2018
Primary completion
Apr 19, 2022
Completion
Apr 19, 2022
Last update posted
Nov 19, 2025

2018 – 2022

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Essential Access Health Los Angeles California 30010
University of California, Davis Sacramento California 95817
University of California, San Francisco San Francisco California 94110
University of Colorado Denver Colorado 80045
University of Hawaii Honolulu Hawaii 96826
University of Chicago Chicago Illinois 60637
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224
Planned Parenthood League of Massachusetts Boston Massachusetts 02215
Bellevue Hospital Center New York New York 10016
Columbia University New York New York 10032
University of Cincinnati-Holmes Hospital Cincinnati Ohio 45267
University Hospitals of Cleveland MacDonald Women's Hospital Cleveland Ohio 44106
Oregon Health Science University Portland Oregon 97239
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh/Magee Women's Hospital Pittsburgh Pennsylvania 15213
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905
University of Utah Salt Lake City Utah 84106
Eastern Virginia Medical School Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03537768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2025 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03537768 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →